We are live on ! Find out more
XBIT icon

XBiotech
XBIT

61 hedge funds and large institutions have $46.8M invested in XBiotech in 2021 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 13 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

69% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 13

1.66% less ownership

Funds ownership: 15.49% → 13.84% (-1.7%)

8% less funds holding

Funds holding: 66 → 61 (-5)

17% less capital invested

Capital invested by funds: $56.7M → $46.8M (-$9.86M)

31% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 16

65% less call options, than puts

Call options by funds: $233K | Put options by funds: $674K

Holders
61
Holders Change
-5
Holders Change %
-7.58%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
22
Reduced
13
Closed
16
Calls
$233K
Puts
$674K
Net Calls
-$441K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$868K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$727K
3
Marshall Wace
Marshall Wace
United Kingdom
+$315K
4
CS
Credit Suisse
Switzerland
+$269K
5
TI
Trexquant Investment
Connecticut
+$269K

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$4.56M
2
BlackRock
BlackRock
New York
-$2.19M
3
Wells Fargo
Wells Fargo
California
-$1.43M
4
Citadel Advisors
Citadel Advisors
Florida
-$619K
5
Northern Trust
Northern Trust
Illinois
-$524K
Name Holding Trade Value Shares
Change 		Change in
Stake
SO
26
STRS Ohio
Ohio
$228K – – –
Millennium Management
27
Millennium Management
New York
$209K +$49.3K +3,787 +25%
Barclays
28
Barclays
United Kingdom
$206K +$159K +12,220 +195%
E
29
Ergoteles
New York
$158K +$185K +14,200 New
TNB
30
Thomasville National Bank
Georgia
$149K – – –
Susquehanna International Group
31
Susquehanna International Group
Pennsylvania
$145K +$38.2K +2,938 +29%
BNP Paribas Financial Markets
32
BNP Paribas Financial Markets
France
$145K +$109K +8,409 +182%
LSA
33
Leonteq Securities AG
Switzerland
$145K – – –
SF
34
Synovus Financial
Georgia
$131K – – –
UBS Group
35
UBS Group
Switzerland
$129K +$76.6K +5,884 +103%
AIMCA
36
Alberta Investment Management Corp (AIMCo)
Alberta, Canada
$126K +$147K +11,300 New
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$123K -$68.2K -5,240 -32%
CANY
38
Caxton Associates (New York)
New York
$115K – – –
LFM
39
LGT Fund Management
Liechtenstein
$111K +$130K +10,000 New
EMG
40
ETF Managers Group
New Jersey
$103K -$24.8K -1,904 -17%
Deutsche Bank
41
Deutsche Bank
Germany
$103K +$6.38K +490 +6%
JP Morgan Chase
42
JP Morgan Chase
New York
$98K +$8.02K +616 +8%
AIG
43
American International Group
New York
$90K -$3.15K -242 -3%
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$72K -$66.6K -5,115 -44%
Legal & General Group
45
Legal & General Group
United Kingdom
$56K – – –
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$51K +$16.9K +1,298 +40%
Citigroup
47
Citigroup
New York
$47K +$7.29K +560 +15%
Nisa Investment Advisors
48
Nisa Investment Advisors
Missouri
$32K -$13K -1,000 -25%
Zurich Cantonal Bank
49
Zurich Cantonal Bank
Switzerland
$24K – – –
HNWAG
50
High Net Worth Advisory Group
Florida
$17K +$19.5K +1,500 New
1
2
3 4

XBIT Hedge Fund Activity: Q4 2021 in Review

61 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in XBiotech (XBIT) for Q4 2021, worth a combined $46.8M — down 17% from $56.7M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of XBIT and 11 opened new positions — a net loss of 5 holders — while 13 trimmed existing stakes and 22 added.

The largest buyer was Dimensional Fund Advisors, adding an estimated $868K. The largest seller was Oracle Investment Management, exiting entirely with an estimated $4.56M sold.

  • 61 institutional investors held XBiotech (XBIT) as of Q4 2021, down from 66 in Q3 2021.
  • Funds reported $46.8M of XBiotech stock for Q4 2021, down 17% quarter-over-quarter.
  • 11 funds opened new XBiotech positions in Q4 2021 and 16 closed out, a net change of -5 holders.
  • The largest XBiotech buyer in Q4 2021 was Dimensional Fund Advisors, an estimated $868K added.
  • The largest XBiotech seller in Q4 2021 was Oracle Investment Management, an estimated $4.56M sold.

Based on aggregated 13F filings for Q4 2021.